Literature DB >> 24133602

Biclonal light chain gammopathy with aberrant CD33 expression in secondary plasma cell leukemia.

Michael Gentry1, Mark Pettenati, Changlee S Pang.   

Abstract

Plasma cell leukemia is a rare neoplastic proliferation of circulating plasma cells. Clonal proliferations of plasma cells, such as in plasma cell leukemia or plasma cell myeloma, are typically characterized by production of a monoclonal heavy and/or light chain immunoglobulin. We present a case of a secondary plasma cell leukemia arising from plasma cell myeloma with dual expression of lambda and kappa light chains along with aberrant expression of CD33, CD20, and dim CD56. This case emphasizes the importance of recognizing aberrant immunophenotypes in plasma cell leukemias and represents the first reported case of biclonal light chain expression in a secondary plasma cell leukemia.

Entities:  

Keywords:  Plasma cell leukemia; aberrant immunophenotype; biclonal gammopathy

Mesh:

Substances:

Year:  2013        PMID: 24133602      PMCID: PMC3796246     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  15 in total

1.  CD33 is expressed on plasma cells of a significant number of myeloma patients, and may represent a therapeutic target.

Authors:  N Robillard; S Wuillème; L Lodé; F Magrangeas; S Minvielle; H Avet-Loiseau
Journal:  Leukemia       Date:  2005-11       Impact factor: 11.528

2.  Primary plasma cell leukemia with initial cutaneous involvement and IgA biclonal gammopathy.

Authors:  Arnab Chattopadhyay; Uttam Kumar Nath; Rajib De; Anup Singh; Subhaprakash Sanyal; Sanjoy Kumar Chatterjee; Utpal Chaudhuri
Journal:  Ann Hematol       Date:  2007-10-02       Impact factor: 3.673

3.  Leukemic myelomatosis (plasma cell leukemia); a review with report of four cases.

Authors:  J BICHEL; P EFFERSØE; H GORMSEN; N HARBOE
Journal:  Acta radiol       Date:  1952 Mar-Apr       Impact factor: 1.990

4.  Clinicopathological and prognostic characteristics of CD33-positive multiple myeloma.

Authors:  Naohi Sahara; Kazunori Ohnishi; Takaaki Ono; Yuya Sugimoto; Miki Kobayashi; Kaori Takeshita; Kazuyuki Shigeno; Satoki Nakamura; Kensuke Naito; Sadahiro Tamashima; Kenji Nara; Tadasu Tobita; Akihiro Takeshita; Ryuzo Ohno
Journal:  Eur J Haematol       Date:  2006-07       Impact factor: 2.997

5.  Flow cytometric immunophenotypic characteristics of 36 cases of plasma cell leukemia.

Authors:  Maria Kraj; Joanna Kopeć-Szlęzak; Ryszard Pogłód; Barbara Kruk
Journal:  Leuk Res       Date:  2011-02       Impact factor: 3.156

6.  Genetic abnormalities and patterns of antigenic expression in multiple myeloma.

Authors:  Gema Mateo; Mariana Castellanos; Ana Rasillo; Norma C Gutiérrez; Ma Angeles Montalbán; Ma Luisa Martín; Jesús Ma Hernández; Ma Consuelo López-Berges; Laura Montejano; Joan Bladé; Ma Victoria Mateos; Anna Sureda; Javier de la Rubia; Joaquín Díaz-Mediavilla; Atanasio Pandiella; Juan José Lahuerta; Alberto Orfao; Jesús F San Miguel
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

7.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

8.  Genetic aberrations and survival in plasma cell leukemia.

Authors:  R E Tiedemann; N Gonzalez-Paz; R A Kyle; R Santana-Davila; T Price-Troska; S A Van Wier; W J Chng; R P Ketterling; M A Gertz; K Henderson; P R Greipp; A Dispenzieri; M Q Lacy; S V Rajkumar; P L Bergsagel; A K Stewart; R Fonseca
Journal:  Leukemia       Date:  2008-01-24       Impact factor: 11.528

9.  The clinical aspects of biclonal gammopathies. Review of 57 cases.

Authors:  R A Kyle; R A Robinson; J A Katzmann
Journal:  Am J Med       Date:  1981-12       Impact factor: 4.965

10.  Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.

Authors:  R García-Sanz; A Orfão; M González; M D Tabernero; J Bladé; M J Moro; J Fernández-Calvo; M A Sanz; J A Pérez-Simón; A Rasillo; J F Miguel
Journal:  Blood       Date:  1999-02-01       Impact factor: 22.113

View more
  3 in total

1.  Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.

Authors:  Shahanawaz Jiwani; Joshua Bornhost; Daisy Alapat
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

2.  Localized Gastric Amyloidosis with Kappa and Lambda Light Chain Co-Expression.

Authors:  Yong Hwan Ahn; Ye Young Rhee; Suck Chei Choi; Geom Seog Seo
Journal:  Clin Endosc       Date:  2017-10-26

3.  A case of solitary plasmacytoma of bone showing co-expression of both immunoglobulin light chains.

Authors:  Ryota Matsuoka; Noriaki Sakamoto; Takayasu Kato; Shigeru Chiba; Masayuki Noguchi
Journal:  Eur J Med Res       Date:  2021-12-20       Impact factor: 2.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.